New Horizon Health (FRA:6YZ) ROE % Adjusted to Book Value: 2.58% (As of Jun. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:6YZ New Horizon Health Ltd FRA:6YZ
35 GF Score
Price €1.62
View Full Analysis

What is New Horizon Health ROE % Adjusted to Book Value?

New Horizon Health FRA:6YZ 35 ROE % Adjusted to Book Value is 2.58% as of Jun. 2023. GuruFocus rates FRA:6YZ with a GF Score™ of 35/100.

New Horizon Health's ROE % for the quarter that ended in Jun. 2023 was 9.64%. New Horizon Health's PB Ratio for the quarter that ended in Jun. 2023 was 3.73. New Horizon Health's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2023 was 2.58%.

New Horizon Health ROE % Adjusted to Book Value Related Terms

New Horizon Health ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for New Horizon Health's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

New Horizon Health ROE % Adjusted to Book Value Chart

New Horizon Health Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22
ROE % Adjusted to Book Value
0.00 0.00 0.00 -151.11 -1.30

New Horizon Health Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only 0.00 -5.06 -1.54 -0.46 2.58

FRA:6YZ vs ABT, SYK, MDT: ROE % Adjusted to Book Value Comparison

For the Medical Devices subindustry, New Horizon Health's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

New Horizon Health ROE % Adjusted to Book Value vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, New Horizon Health's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where New Horizon Health's ROE % Adjusted to Book Value falls into.


FRA:6YZ
35GF Score
New Horizon Health Ltd FRA:6YZ
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

New Horizon Health ROE % Adjusted to Book Value Calculation

New Horizon Health's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2022 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-3.68% / 2.84
=-1.30%

New Horizon Health's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=9.64% / 3.73
=2.58%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 2.58% mean?
New Horizon Health (FRA:6YZ) has a ROE % Adjusted to Book Value of 2.58% as of Jun. 2023. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on New Horizon Health and its competitors.
Is New Horizon Health's ROE % Adjusted to Book Value too high?
New Horizon Health's current ROE % Adjusted to Book Value is 2.58%. Overall, New Horizon Health has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does New Horizon Health's ROE % Adjusted to Book Value compare to ABT and SYK?
New Horizon Health's ROE % Adjusted to Book Value of 2.58% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Devices & Instruments company?
A good ROE % Adjusted to Book Value depends on the Medical Devices & Instruments industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on New Horizon Health and its competitors. New Horizon Health's current ROE % Adjusted to Book Value is 2.58%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is New Horizon Health stock overvalued right now?
New Horizon Health (FRA:6YZ) has a current ROE % Adjusted to Book Value of 2.58%. The current ROE % Adjusted to Book Value is 2.58%. New Horizon Health's overall GF Score™ is 35/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For New Horizon Health (FRA:6YZ), the current ROE % Adjusted to Book Value is 2.58% as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

New Horizon Health Business Description

Address 400 Jiang’er Road, 13th Floor, T1 Building, Binjiang District, Zhejiang, Hangzhou, CHN, 310052
New Horizon Health Ltd is engaged in early cancer screening and in-home testing in China. The company has an early detection and cancer screening-focused pipeline of five products and product candidates with an emphasis on colorectal cancer screening. The company focuses on cancer prevention and cure through screening and early detection. It generates maximum revenue from ColoClear and Pupu Tube products.
35GF Score

Get the complete analysis for FRA:6YZ

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.62
Price